# Long Term Implications of Rare Brain Tumours'

> **NCT04708548** · — · COMPLETED · sponsor: **Galina Velikova** · enrollment: 267 (actual)

## Conditions studied

- Quality of Life
- Cognitive Impairment
- WHO Grade II Oligodendroglial Tumor
- WHO Grade III Oligodendroglial Tumor
- Long-term Effects of Cancer Treatment
- Health-related Quality of Life

## Interventions

- **OTHER:** Health-related Quality of Life
- **OTHER:** Psychological Distress
- **OTHER:** Fatigue
- **OTHER:** Cognitive Functioning

## Key facts

- **NCT ID:** NCT04708548
- **Lead sponsor:** Galina Velikova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-29
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2023-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04708548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04708548, "Long Term Implications of Rare Brain Tumours'". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04708548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*